COLLAND; Frederic

Patent Applications and Registrations

Patent applications and USPTO patent grants for COLLAND; Frederic.The latest application filed is for "3,6-diamino-pyridazin-3-yl derivatives, pharmaceutical compositions containing them and their uses as pro-apoptotic agents".

Company Profile

0.7.17

COLLAND; Frederic - Puiseux-en-France FR
Colland; Frederic - Issy-les-Moulineaux FR
Colland; Frederic - Puiseux FR
Colland, Frederic - Fosses FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
3,6-diamino-pyridazin-3-yl Derivatives, Pharmaceutical Compositions Containing Them And Their Uses As Pro-apoptotic Agents App 20220289734 - DAVIDSON; James Edward Paul ; et al.	2022-09-15
Bcl-2 Inhibitors For Use In The Treatment Of A Bcl-2 Mediated Cancer Carrying The Gly101val Mutation App 20220211718 - MURRAY; James Brooke ; et al.	2022-07-07
Substituted quinazolin-4-ones for inhibiting ubiquitin specific protease 7 Grant 9,546,150 - Colland , et al. January 17, 2	2017-01-17
Selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications Grant 9,328,093 - Lopez , et al. May 3, 2	2016-05-03
Novel Selective Inhibitors Of Ubiquitin Specific Protease 7, The Pharmaceutical Compositions Thereof And Their Therapeutic Applications App 20150072973 - Lopez; Roman ; et al.	2015-03-12
Selective and Reversible Inhibitors of Ubiquitin Specific Protease 7 App 20140371247 - Colland; Frederic ; et al.	2014-12-18
Cysteine protease inhibitors and their therapeutic applications Grant 8,648,076 - Guedat , et al. February 11, 2	2014-02-11
Novel Selective Inhibitors Of Ubiquitin Specific Protease 7, The Pharmaceutical Compositions Thereof And Their Therapeutic Applications App 20130023521 - Lopez; Roman ; et al.	2013-01-24
Ubiquitin Specific Proteases Responsible For Mcl-1 Stability And Uses Thereof App 20110237644 - Geneste; Olivier ; et al.	2011-09-29
Novel Selective Inhibitors of Ubiquitin Specific Protease 7, the Pharmaceutical Compositions Thereof and Their Therapeutic Applications App 20110177105 - Lopez; Roman ; et al.	2011-07-21
Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications Grant 7,875,613 - Guedat , et al. January 25, 2	2011-01-25
Novel Tetracyclic Inhibitors Of Cysteine Proteases, The Pharmaceutical Compositions Thereof And Their Therapeutic Applications App 20100048575 - Guedat; Philippe ; et al.	2010-02-25
Novel Cysteine Protease Inhibitors And Their Therapeutic Applications App 20090215786 - Guedat; Philippe ; et al.	2009-08-27
Novel Inhibitors of Cysteine Proteases, the Pharmaceutical Compositions Thereof and their Therapeutic Applications App 20090181972 - Guedat; Philippe ; et al.	2009-07-16
Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications Grant 7,462,615 - Guedat , et al. December 9, 2	2008-12-09
Novel Tetracyclic Inhibitors Of Cysteine Proteases, The Pharmaceutical Compositions Thereof And Their Therapeutic Applications App 20080103149 - GUEDAT; Philippe ; et al.	2008-05-01
Novel inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications App 20070135439 - Guedat; Philippe ; et al.	2007-06-14
Novel cysteine protease inhibitors and their therapeutic applications App 20070032499 - Guedat; Philippe ; et al.	2007-02-08
Use of specified tcf target genes to identify drugs for the treatment of cancer in particular colorectal cancer in which tcf/ss-cateini/wnt signalling plays a central role App 20060165699 - Colland; Frederic ; et al.	2006-07-27
Anti-sigma28 factors in Helicobacter pylori, Campylobacter jejuni and Pseudomonas aeruginosa and applications thereof App 20020192796 - Legrain, Pierre ; et al.	2002-12-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.